Zeitschrift für Kristallographie - New Crystal Structures,
Год журнала:
2023,
Номер
238(5), С. 1013 - 1015
Опубликована: Авг. 18, 2023
Abstract
C
23
H
25
BrO
6
,
triclinic,
P
1‾
$\overline{1}$
(no.
2),
a
=
7.8451(3)
Å,
b
7.9428(2)
c
17.6360(6)
α
90.146(3),
β
90.433(3)
∘
γ
99.307(3)
V
1084.44(7)
Å
3
Z
2,
R
gt
(
F
)
0.0464,
wR
ref
2
0.1402,
T
297.37(10)
K.
Abstract
In
quest
of
generating
a
diverse
array
potential
cytotoxic
candidates
through
molecular
hybridization
approach,
herein
we
have
designed
library
forty‐one
morpholine‐functionalized
aurones
7(a–ao),
each
with
distinct
substitution
pattern.
These
were
obtained
by
reacting
6‐hydroxyaurones,
4‐(2‐chloroethyl)morpholine
hydrochloride,
characterized
various
spectroscopic
techniques
including
single
crystal
XRD
(7b)
and
in‐vitro
screened
for
their
antiproliferative
against
human
gastric
adenocarcinoma
(AGS)
cells.
Most
the
synthesized
compounds
exhibited
excellent
results.
Twenty
analogs
found
to
better
than
reference
drug
Leucovorin
analog
7j
emerged
as
most
potent
IC
50
=5.98
μM
nearly
one
fifth
standard
(IC
=30.8
μM).
This
library,
consisting
twenty
three
novel
eighteen
reported
aurones,
bearing
pattern,
further
helped
in
making
concrete
structure‐activity
relationship
potential.
Additionally,
in‐silico
docking,
Hirshfeld
surface
analysis
two
dimensional
fingerprint
plots
also
studied
understand
interactions
structural
aspects.
Further
computational
investigations
these
conducted
using
DFT/B3LYP
method,
determination
HOMO
LUMO
energy
values
well
calculation
chemical
softness,
hardness,
electronegativity
electrophilic
index
etc.
Viruses,
Год журнала:
2025,
Номер
17(4), С. 491 - 491
Опубликована: Март 28, 2025
The
SARS-CoV-2
proteases
Mpro
and
PLpro
are
critical
targets
for
antiviral
drug
development
the
treatment
of
COVID-19.
1,2,4-thiadiazole
functional
group
is
an
inhibitor
cysteine
proteases,
such
as
papain
cathepsins.
This
chemical
moiety
also
present
in
ceftaroline
fosamil
(CF),
FDA-approved
fifth-generation
cephalosporin
antibiotic.
study
investigates
interactions
between
CF,
its
primary
metabolites
(M1
dephosphorylated
CF
M2
opened
β-lactam
ring)
derivatives
(protonated
M1H
M2H),
open
rings
(open-M1H
open-M2H)
with
evaluates
CF’s
effects
on
vitro
viral
replication.
In
silico
analyses
(molecular
docking
molecular
dynamics
(MD)
simulations)
demonstrated
that
potential
inhibitors
Mpro.
Docking
analysis
indicated
majority
ligands
were
more
stable
than
PLpro;
however,
biochemical
preferred
target
CF.
inhibited
replication
human
Calu-3
cell
model
at
submicromolar
concentrations
when
added
to
culture
medium
12
h.
Our
results
suggest
should
be
evaluated
a
repurposing
agent
COVID-19,
considering
not
only
but
other
relevant
cellular
pathways.
Additionally,
reactivity
sulfur
warrants
further
exploration
protease
inhibitors.
Viruses,
Год журнала:
2025,
Номер
17(4), С. 518 - 518
Опубликована: Апрель 1, 2025
Despite
extensive
efforts,
no
highly
effective
antiviral
molecule
exists
for
treating
moderate
and
severe
COVID-19.
Nanotechnology
has
emerged
as
a
promising
approach
developing
novel
drug
delivery
systems
to
enhance
efficacy.
Among
these,
polymeric
nanomicelles
improve
the
solubility,
bioavailability,
cellular
uptake
of
therapeutic
agents.
In
this
study,
Pluronic
F127-based
were
developed
evaluated
their
activity
against
SARS-CoV-2.
The
nanomicelles,
formulated
using
direct
dissolution
method,
exhibited
an
average
size
37.4
±
8.01
nm
polydispersity
index
(PDI)
0.427
0.01.
Their
efficacy
was
assessed
in
SARS-CoV-2-infected
Vero
E6
Calu-3
cell
models,
where
treatment
with
1:2
dilution
inhibited
viral
replication
by
more
than
90%.
Cytotoxicity
assays
confirmed
non-toxic
both
lines
after
72
h.
cells
(human
type
II
pneumocyte
model),
containing
atazanavir
(ATV)
significantly
reduced
replication,
even
under
high
MOI
(2)
48
h,
while
also
preventing
IL-6
upregulation.
To
investigate
mechanism,
pretreatment
showed
inhibitory
effect.
However,
pre-exposure
led
significant
reduction
(>85%
>75%
1:4
dilutions,
respectively),
transmission
electron
microscopy.
These
findings
highlight
nanotechnology-driven
strategy
SARS-CoV-2,
reinforcing
potential
future
therapies.
Molecules,
Год журнала:
2023,
Номер
28(18), С. 6696 - 6696
Опубликована: Сен. 19, 2023
The
understanding
that
zidovudine
(ZDV
or
azidothymidine,
AZT)
inhibits
the
RNA-dependent
RNA
polymerase
(RdRp)
of
SARS-CoV-2
and
chalcogen
atoms
can
increase
bioactivity
reduce
toxicity
AZT
has
directed
our
search
for
discovery
novel
potential
anti-coronavirus
compounds.
Here,
antiviral
activity
selenium
tellurium
containing
derivatives
in
human
type
II
pneumocytes
cell
model
(Calu-3)
monkey
kidney
cells
(Vero
E6)
infected
with
SARS-CoV-2,
their
toxic
effects
on
these
cells,
was
evaluated.
Cell
viability
analysis
revealed
organoselenium
(R3a-R3e)
showed
lower
cytotoxicity
than
organotellurium
(R3f,
R3n-R3q),
CC50
≥
100
µM.
R3b
R3e
were
particularly
noteworthy
inhibiting
viral
replication
both
models
better
selectivity
index.
In
Vero
E6,
EC50
values
2.97
±
0.62
µM
1.99
0.42
µM,
respectively,
while
Calu-3,
concentrations
3.82
1.42
1.92
0.43
(24
h
treatment)
1.33
0.35
2.31
0.54
(48
h)
observed,
respectively.
molecular
docking
calculations
carried
out
to
main
protease
(Mpro),
papain-like
(PLpro),
RdRp
following
non-competitive,
competitive,
allosteric
inhibitory
approaches.
silico
results
suggested
is
a
non-competitive
inhibitor
RdRp,
interacting
cavity
located
palm
region.
Overall,
cell-based
indicated
chalcogen-zidovudine
more
potent
compounds
play
an
important
role,
expanding
knowledge
about
promising
therapeutic
capacity
against
COVID-19.
Pharmaceuticals,
Год журнала:
2024,
Номер
17(4), С. 436 - 436
Опубликована: Март 28, 2024
The
LABEXTRACT
plant
extract
bank,
featuring
diverse
members
of
the
Myrtaceae
family
from
Brazilian
hot
spot
regions,
provides
a
promising
avenue
for
bioprospection.
Given
pivotal
roles
Spike
protein
and
3CLpro
PLpro
proteases
in
SARS-CoV-2
infection,
this
study
delves
into
correlations
between
species
Atlantic
Forest
these
targets,
as
well
an
antiviral
activity
through
both
vitro
silico
analyses.
results
uncovered
notable
inhibitory
effects,
with
Eugenia
prasina
E.
mosenii
standing
out,
while
proved
to
be
multitarget,
presenting
inhibition
values
above
72%
three
targets
analyzed.
All
extracts
inhibited
viral
replication
Calu-3
cells
(EC50
was
lower
than
8.3
µg·mL−1).
Chemometric
analyses,
LC-MS/MS,
encompassing
prediction
models
molecular
networking,
identified
potential
active
compounds,
such
myrtucommulones,
described
literature
their
activity.
Docking
analyses
showed
that
one
undescribed
myrtucommulone
(m/z
841
[M
−
H]−)
had
higher
fitness
score
when
interacting
study,
including
ACE2,
Spike,
SARS-CoV-2.
Also,
concludes
extracts,
particularly
prasina,
exhibit
effects
against
crucial
stages
infection.
Compounds
like
myrtucommulones
emerge
anti-SARS-CoV-2
agents,
warranting
further
exploration.
Viruses,
Год журнала:
2024,
Номер
16(11), С. 1768 - 1768
Опубликована: Ноя. 13, 2024
Endemic
and
pandemic
viruses
represent
significant
public
health
challenges,
leading
to
substantial
morbidity
mortality
over
time.
The
COVID-19
has
underscored
the
urgent
need
for
development
discovery
of
new,
potent
antiviral
agents.
In
this
study,
we
present
synthesis
anti-SARS-CoV-2
activity
a
series
benzocarbazoledinones,
assessed
using
cell-based
screening
assays.
Our
results
indicate
that
four
compounds
(4a,
4b,
4d,
4i)
exhibit
EC50
values
below
4
μM
without
cytotoxic
effects
in
Calu-3
cells.
Mechanistic
investigations
focused
on
inhibition
SARS-CoV-2
main
protease
(Mpro)
papain-like
(PLpro)
have
used
enzymatic
Notably,
4a
4b
showed
Mpro
with
IC50
0.11
±
0.05
0.37
µM,
respectively.
Furthermore,
silico
molecular
docking,
physicochemical,
pharmacokinetic
studies
were
conducted
validate
mechanism
assess
bioavailability.
Compound
was
selected
preliminary
drug-likeness
analysis
vivo
pharmacokinetics
investigations,
which
yielded
promising
corroborated
vitro
findings,
reinforcing
its
potential
as
an
lead
compound.
Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 4, 2023
Abstract
Aurones
and
indanones
were
proved
to
be
potential
antibacterial
agents
in
our
recent
work.
Based
on
strategy
of
bioisosterism
diene
insertion,
a
series
aurone
indanone
derivatives
designed
synthesized,
then
submitted
the
activity
evaluation
C.
albicans,
E.
coli
S.
aureus
.
According
results,
nineteen
thirty
synthesized
compounds
had
inhibitory
against
at
least
one
bacterium.
The
minimum
value
MIC
was
62.5
µM
(
A2
,
B1
B3
B4
B8
C6
D1
D2
)
MBC
).
In
addition,
molecular
docking
ADMET
prediction
also
applied
possible
binding
mode
druggability
active
compounds.
Our
research
once
again
demonstrated
that
are
good
scaffolds
for
development
agents,
especially
bacterial.